Form 8-K - Current report:
SEC Accession No. 0001104659-25-055322
Filing Date
2025-06-02
Accepted
2025-06-02 12:01:30
Documents
52
Period of Report
2025-06-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2516844d2_8k.htm   iXBRL 8-K 23831
2 EXHIBIT 99.1 tm2516844d2_ex99-1.htm EX-99.1 58218
3 GRAPHIC tm2516844d2_ex99-1img001.jpg GRAPHIC 120197
4 GRAPHIC tm2516844d2_ex99-1img002.jpg GRAPHIC 436566
5 GRAPHIC tm2516844d2_ex99-1img003.jpg GRAPHIC 175699
6 GRAPHIC tm2516844d2_ex99-1img004.jpg GRAPHIC 70455
7 GRAPHIC tm2516844d2_ex99-1img005.jpg GRAPHIC 203797
8 GRAPHIC tm2516844d2_ex99-1img006.jpg GRAPHIC 208185
9 GRAPHIC tm2516844d2_ex99-1img007.jpg GRAPHIC 122673
10 GRAPHIC tm2516844d2_ex99-1img008.jpg GRAPHIC 156811
11 GRAPHIC tm2516844d2_ex99-1img009.jpg GRAPHIC 169895
12 GRAPHIC tm2516844d2_ex99-1img010.jpg GRAPHIC 277747
13 GRAPHIC tm2516844d2_ex99-1img011.jpg GRAPHIC 191928
14 GRAPHIC tm2516844d2_ex99-1img012.jpg GRAPHIC 161942
15 GRAPHIC tm2516844d2_ex99-1img013.jpg GRAPHIC 205652
16 GRAPHIC tm2516844d2_ex99-1img014.jpg GRAPHIC 162299
17 GRAPHIC tm2516844d2_ex99-1img015.jpg GRAPHIC 166586
18 GRAPHIC tm2516844d2_ex99-1img016.jpg GRAPHIC 168399
19 GRAPHIC tm2516844d2_ex99-1img017.jpg GRAPHIC 350099
20 GRAPHIC tm2516844d2_ex99-1img018.jpg GRAPHIC 170421
21 GRAPHIC tm2516844d2_ex99-1img019.jpg GRAPHIC 207090
22 GRAPHIC tm2516844d2_ex99-1img020.jpg GRAPHIC 117886
23 GRAPHIC tm2516844d2_ex99-1img021.jpg GRAPHIC 113380
24 GRAPHIC tm2516844d2_ex99-1img022.jpg GRAPHIC 252936
25 GRAPHIC tm2516844d2_ex99-1img023.jpg GRAPHIC 311956
26 GRAPHIC tm2516844d2_ex99-1img024.jpg GRAPHIC 203450
27 GRAPHIC tm2516844d2_ex99-1img025.jpg GRAPHIC 222752
28 GRAPHIC tm2516844d2_ex99-1img026.jpg GRAPHIC 173223
29 GRAPHIC tm2516844d2_ex99-1img027.jpg GRAPHIC 149547
30 GRAPHIC tm2516844d2_ex99-1img028.jpg GRAPHIC 183967
31 GRAPHIC tm2516844d2_ex99-1img029.jpg GRAPHIC 249002
32 GRAPHIC tm2516844d2_ex99-1img030.jpg GRAPHIC 215159
33 GRAPHIC tm2516844d2_ex99-1img031.jpg GRAPHIC 183155
34 GRAPHIC tm2516844d2_ex99-1img032.jpg GRAPHIC 210242
35 GRAPHIC tm2516844d2_ex99-1img033.jpg GRAPHIC 209366
36 GRAPHIC tm2516844d2_ex99-1img034.jpg GRAPHIC 81446
37 GRAPHIC tm2516844d2_ex99-1img035.jpg GRAPHIC 240982
38 GRAPHIC tm2516844d2_ex99-1img036.jpg GRAPHIC 208967
39 GRAPHIC tm2516844d2_ex99-1img037.jpg GRAPHIC 67312
40 GRAPHIC tm2516844d2_ex99-1img038.jpg GRAPHIC 236406
41 GRAPHIC tm2516844d2_ex99-1img039.jpg GRAPHIC 91339
  Complete submission text file 0001104659-25-055322.txt   10531471

Data Files

Seq Description Document Type Size
42 XBRL TAXONOMY EXTENSION SCHEMA vstm-20250602.xsd EX-101.SCH 3014
43 XBRL TAXONOMY EXTENSION LABEL LINKBASE vstm-20250602_lab.xml EX-101.LAB 34239
44 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vstm-20250602_pre.xml EX-101.PRE 22358
54 EXTRACTED XBRL INSTANCE DOCUMENT tm2516844d2_8k_htm.xml XML 3675
Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Filer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35403 | Film No.: 251013762
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)